ReviewJournal of veterinary pharmacology and therapeutics2022

Pharmacology, safety, efficacy and clinical uses of the COX-2 inhibitor robenacoxib.

Peter Lees et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.